A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Ex VIvo DEtermiNed Cancer Therapy
- Status
- RECRUITING
- Phase
- N/A
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
- Status
- RECRUITING
- Phase
- PHASE2
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Video Education With Result Dependent dIsclosure
- Status
- RECRUITING
- Phase
- NA
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
HL-085 in NRAS-mutated Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
- Status
- RECRUITING
- Phase
- N/A
Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
pRospective Evaluation of Clinical Outcomes in Patients With metAsTatIс melanOma Treated With dabrafeNib and trAmetinib in reaL practicE
- Status
- UNKNOWN
- Phase
- N/A
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor
- Status
- UNKNOWN
- Phase
- NA
Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients
- Status
- UNKNOWN
- Phase
- NA
Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2